News

Vilazodone is being developed along with a potential companion biomarker test that will be developed by the PGxHealth division of Clinical Data. Clinical Data plans to issue the

“There are 20 million children and adults living with diabetes in the US, and many of them are undiagnosed until they develop complications,” said Howard Birndorf, Nanogen chairman

Professor Gareth Morris of the school of chemistry and Professor Risto Kauppinen of the University of Birmingham are to lead the development of a new non-invasive technique which

The open label trial is expected to enroll approximately 50 patients with advanced solid tumors or refractory lymphomas at two trial sites – MD Anderson Cancer Center and

The terms of the licenses consist of a single upfront payment to Novogen of $1 million, a series of payments for each compound upon reaching the milestones of

The study, published in the journal Carcinogenesis, is the first to suggest that a “negative energy balance” – produced by increasing the mice's energy output by use of

The European Zomaxx study is a single-arm trial that will evaluate the safety and performance of the Zomaxx zotarolimus-eluting stent in patients with single or two-vessel coronary artery

The clinic will prepare a clinical protocol design for a phase I/II trial to be conducted at the clinic and coordinated by its Cardiovascular Coordinating Center. In addition,

The placebo-controlled trial enrolled 110 healthy adult males at one center in the US. The primary purpose of the study was to investigate the safety, tolerability and pharmacokinetics